Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases.
about
Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptorToll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosisSparstolonin B attenuates hypoxia-induced apoptosis, necrosis and inflammation in cultured rat left ventricular tissue slicesA novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy.Regulatory effects of TLR2 on megakaryocytic cell function.TLR2-deficiency of cKit+ bone marrow cells is associated with augmented potency to stimulate angiogenic processes.Effects of Toll-like receptor signals in T-cell neoplasms.Targeting TLR/IL-1R signalling in human diseases.Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.Targeting inflammation in cardiovascular diseases. still a neglected field?Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis.Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities.Cardioprotective effect of carvedilol: inhibition of apoptosis in H9c2 cardiomyocytes via the TLR4/NF-κB pathway following ischemia/reperfusion injuryGenomics in cardiovascular diseases: analysis of the importance of the toll-like receptor signaling pathwayThe Emerging Role of TLR and Innate Immunity in Cardiovascular Disease.The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases-A Review.Expression of toll-like receptor genes in leukocytes of patients with sudden sensorineural hearing loss.HMGB1 facilitates hypoxia-induced vWF upregulation through TLR2-MYD88-SP1 pathway.The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.
P2860
Q28082430-E620B1EE-F334-4350-BD63-F18DCF2119CEQ33678336-7D5F6F6C-5D5D-4A83-AF65-78BA120EEA7EQ34183935-CC8D5D19-3D45-4BE3-9F76-265582B1F09DQ34519899-711A2E4B-3F54-4C1C-B578-01811BCF0BEAQ35037420-E6F67165-E30C-494A-B7DB-D4C2C58F5323Q35057385-CEB7281E-C0FE-40BD-A5E8-33D1AB8ED81DQ36293678-04C0CA85-C3FF-4A8D-A09D-859E1259AEBEQ37731951-06BE5D8E-35F5-482E-A71C-A2F3C23B98D8Q37765620-DA87A971-4B3C-44A5-98FD-A7A12C098A11Q37925018-3543D334-CE8F-4E99-BB5C-58E7D90D4ADDQ38016490-D73B668D-C2C5-4DD4-85BC-DD6740B4573AQ38053492-738B7D96-CC92-4159-B5D9-A829D34E8421Q42007802-945A00EB-AD19-486A-8BF4-261C7FB18CC5Q42144631-328D2B9C-2A21-495A-995C-16EB811B4F31Q42152131-C2139C24-D5B6-46E0-ACED-7E32338A5899Q47704782-00843232-B472-4C76-971C-3A2B5563FCC9Q50352812-16014488-E2AB-41FB-939B-3A257C88B3E7Q51601980-9A501769-E2B7-42F0-BF78-8B3DE126F3B2Q55181875-1621B58F-0C49-4BC2-94F1-2EADEAFD2692
P2860
Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Innate immunity and toll-like ...... nt of cardiovascular diseases.
@en
Innate immunity and toll-like ...... nt of cardiovascular diseases.
@nl
type
label
Innate immunity and toll-like ...... nt of cardiovascular diseases.
@en
Innate immunity and toll-like ...... nt of cardiovascular diseases.
@nl
prefLabel
Innate immunity and toll-like ...... nt of cardiovascular diseases.
@en
Innate immunity and toll-like ...... nt of cardiovascular diseases.
@nl
P2093
P2860
P1476
Innate immunity and toll-like ...... nt of cardiovascular diseases.
@en
P2093
Elaine Lin
Jane E Freedman
Lea M Beaulieu
P2860
P304
P356
10.1111/J.1755-5922.2009.00077.X
P577
2009-01-01T00:00:00Z